ZCM
ARCT icon

Ziegler Capital Management’s Arcturus Therapeutics ARCT Stock Holding History

Ziegler Capital Management’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$602K Buy
17,819
+1,124
+7% +$39.8K 0.02% 337
2023
Q4 		$526K Hold
16,695
– – 0.02% 355
2023
Q3 		$427K Sell
16,695
-105
-0.6% -$3.23K 0.02% 356
2023
Q2 		$482K Buy
+16,800
New +$457K 0.02% 351

Other funds holding ARCT

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ziegler Capital Management's ARCT Position: Q1 2024 in Review

Ziegler Capital Management increased its Arcturus Therapeutics (ARCT) stake by 6.7% in Q1 2024, buying an estimated $39.8K and bringing the position to 17,819 shares worth $602K. The position accounts for 0.02% of the portfolio, ranked #337.

Ziegler Capital Management first reported a position in ARCT in Q2 2023 and has held it in 4 quarters since. 179 funds tracked by Wall St. Rank hold ARCT as of Q1 2024.

  • Ziegler Capital Management held 17,819 shares of Arcturus Therapeutics worth $602K as of Q1 2024.
  • Ziegler Capital Management bought 1,124 Arcturus Therapeutics shares in Q1 2024, an estimated $39.8K.
  • Arcturus Therapeutics made up 0.02% of Ziegler Capital Management's portfolio in Q1 2024, its #337 holding.
  • Ziegler Capital Management first reported a position in Arcturus Therapeutics in Q2 2023 and has held it in 4 quarters since.
  • 179 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q1 2024.

Based on Ziegler Capital Management's 13F filing for Q1 2024, filed 15 May 2024.